Swiss Pharmaceutical Giant Roche Reports Third-Quarter Sales Up 9 Percent
496587
Swiss pharmaceutical giant Roche on Thursday announced third-quarter sales up 9 percent from the same period last year, driven by strong growth from its two leading cancer treatments.
741054
Eli Lilly and Co. LLY.N on Thursday  said its third-quarter earnings rose as growing demand for its  medicines offset higher spending to market recently approved  treatments.
606856
Pfizer Inc. (PFE.N: Quote, Profile, Research) , the world&#39;s biggest drugmaker, on Wednesday said third-quarter earnings rose on higher sales of key medicines and favorable foreign exchange factors.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
684039
BASEL, Switzerland  - Net profits at Novartis AG  rose by a lower-than-expected 15 percent last year as  restructuring costs weighed, the company reported on Thursday,  but the world's sixth biggest drugmaker said it expects record  sales and profits in 2005.
344137
The economy &#151; helped out by more brisk consumer and business spending &#151; grew at an annual rate of 3.9 percent in the third quarter, a performance that was stronger than previously thought.
624082
Pfizer Inc., the world&#39;s largest drugmaker, said third-quarter earnings jumped 49 percent after merger-related expenses fell and sales of the cholesterol treatment Lipitor rose.
511457
Pfizer Inc. PFE.N, the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose on strong sales of cholesterol treatment Lipitor and  arthritis drug Celebrex.
283402
BASEL, Switzerland  - Profits at Roche Holding AG leapt 34 percent in 2006 on strong sales of cancer treatments Herceptin and Avastin and flu drug Tamiflu but worries over future margins hit the stock on Wednesday.
144217
U.S. prescription drug sales rose 8.3 percent to $274.9 billion last year, fueled by the Medicare drug benefit, increased use of generic medicines and new treatments for diseases such as cancer and diabetes, according to a new report.
302408
Swiss drugmaker Roche beat forecasts  with a 37 percent rise in first-half net income to 4.543  billion Swiss francs ($3.62 billion), boosted by bumper growth  in its cancer drugs.
61288
The world's largest watchmaker, Swatch Group AG, said Wednesday that its 2004 sales rose more than 4 percent to 4.15 billion Swiss francs (&#36;3.49 billion) from 3.97 billion francs the previous year, largely due to good results from its luxury watch business.
692786
NEW YORK - Pfizer Inc. said Wednesday that third quarter earnings, excluding charges, beat Wall Street expectations by a penny, on strong sales of Lipitor and Celebrex medicines.
545098
Swiss pharmaceutical giant Roche reported Wednesday a better-than-expected 2007 net profit of 11.4 billion Swiss francs (10.4 billion dollars, 7.1 billion euros), boosted by cancer drug sales.
343050
The drugmaker posted third-quarter net income of $1.53 billion as revenues increased by double digits, while lower costs offset more spending on research and development.
10796
Net profit in the fourth quarter rose to 753 million euros ($1.09 billion), helped by sales of the blood-thinner Plavix in the United States and cost-cutting measures, the company said.
14014
The Swiss pharmaceutical group Roche signalled Friday that it was ready to consider increasing its three billion dollar offer for US health diagnostics specialist Ventana Medical Systems.